Midgard Science

Genevoyager

Wuhan, China genevoyager.ltd From their website, Nov 2026

  • GLP

Work here? Claim this listing

About

Genevoyager provides AAV, vaccine, in vivo CAR-T, protein, pseudovirus, lentiviral, oncolytic virus, cell line, stem cell, and disease model services. It serves biopharma and research clients with CRO, CDMO, and technology-platform offerings in gene therapy and related biologics work.

Services

  • AAV CDMO

    CDMO services for AAV development and manufacturing.

    CDMO: development & manufacturing

  • Prophylatic/Therapeutic Vaccine Proprietary Technology

    Proprietary technology for prophylactic and therapeutic vaccine work, including cell banking, virus banking, process development, analytical method development, and quality control.

    CDMO: development & manufacturing

  • Lentiviral Vector-Mediated In Vivo CAR-T CRO/CDMO

    CRO/CDMO services for lentiviral vector-mediated in vivo CAR-T with proprietary vector platform, molecular design, manufacturing, and analytics.

  • AAV Drug Screening

    Screening service for AAV-related drug evaluation.

  • Kinase Drug Screening

    Screening service for kinase-targeted drug evaluation.

  • Pharmacodynamic Evaluation

    Pharmacodynamic evaluation services for drug candidates.

    ADME, DMPK & toxicology

  • Pharmacokinetic Studies

    Pharmacokinetic study services for drug candidates.

    ADME, DMPK & toxicology

  • Non-GLP Nonclinical Safety Evaluation

    Non-GLP nonclinical safety evaluation services.

    ADME, DMPK & toxicology

21 more services
  • AAV Neutralizing Antibody Assay
  • Protein Expression
  • Polypeptide Expression
  • Virus-like Particles (VLPs)
  • Lentiviral Packaging Service
  • Oncolytic Viruses Service
  • Cell Line Construction
  • Gene-Modified Mesenchymal Stem Cell (MSC)
  • In Vitro Diagnostic Raw Materials
  • Neutralizing Antibody Assays
  • One-Bac 4.0 System
  • Molecular Cloning and Screening Platform
  • Animal Disease Model Construction Platform
  • Neutralizing Antibody Detection Platform
  • Thyroperoxidase (TPO) — Diagnostic Raw Materials for GMP
  • AAV Products
  • Proprietary Technology for AAV / Vaccine / in vivo CAR-T CDMO
  • Innovative Drug Non-clinical Evaluation CRO Service
  • Directed Evolution of AAV CRO Service
  • Protein and VLP Service
  • Stem Cell Service

Capabilities

Assays and studies
  • AAV
  • Lentivirus
  • In vivo
  • Antibodies
  • Cell therapy
  • Analytical development
11 more
  • PK/PD
  • Process development
  • Peptides
  • AAV neutralizing antibody assay
  • Neutralizing antibody assays
  • Neutralizing antibody detection
  • AAV drug screening
  • Kinase drug screening
  • Pharmacodynamic evaluation
  • Drug screening
  • Pharmacokinetic studies
Therapeutic areas
  • Gene therapy
  • Vaccines
  • Alzheimer’s disease
  • Atherosclerosis
  • Autoimmune disease
  • Infectious disease

Modalities and species

Modalities
  • Antibody
  • Peptide
  • Viral vector
  • Cell therapy
  • Vaccine
Species and models
  • Alzheimer’s Disease (AD) model
  • AAV-PCSK9 atherosclerosis model
  • AAV-1.3×HBV
  • AAV-1.2×HDV
  • Mesenchymal stem cell (MSC)
  • One-Bac 4.0 System

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

  • GLPSelf-reported

  • ISO 9001Self-reported

Industries served

  • Biotech

Details

Type
CRDMO
Founded
2014
Office
3675 Market Street, Suite 200, Philadelphia, PA 19104

Similar labs